Phenytoin
Dilantin Infatabs, Dilantin-125, Extended Phenytoin Sodium, Phenytek, Phenytoin Infatabs
Anti-epileptic Agent
NADAC/unit
$0.0838
No Shortage
Tier 1: 91.5%
PA Req: 0.9%
11 Manufacturers
15 ANDAs
Phenytoin prevents seizures by stabilizing electrical activity in the brain.
vs. brand Dilantin Infatabs: Generic saves up to 99% per unit
Market Intelligence
2023-11-15 Class II Recall: Amneal Pharmaceuticals of New York, LLC
2023-06-21 Class II Recall: Amneal Pharmaceuticals of New York, LLC
Generic Manufacturers
ACELLA PHARMACEUTICALS LLCAMNEAL PHARMACEUTICALS NY LLCAUROBINDO PHARMA LTDEPIC PHARMA LLCHIKMA PHARMACEUTICALS USA INCMANKIND PHARMA LTDMYLAN PHARMACEUTICALS INCPHARMACIA AND UPJOHN CO LLCRISING PHARMA HOLDINGS INCTARO PHARMACEUTICAL INDUSTRIES LTDVIATRIS SPECIALTY LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.